Checking for Early Lung Cancer With Low-Dose CT Scans in Mexico
Tests yearly low-dose CT scans to find lung cancer early in high-risk adults.
Plain-language title generated from the registry record
Registry title: Lung Cancer Screening Program in Mexico
Key facts
- Where
- Mexico City, MexicoSee the site
Where in Mexico
- Instituto Nacional de Cancerologia (INCan) MexicoMexico City, MexicoTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Instituto Nacional de Cancerologia de Mexico
- Trial code
- NCT06535451
- Record updated
- 24 December 2025
- Original description
This prospective study aims to detect early-stage lung cancer using low-dose computed tomography (LDCT) in Mexicans aged 50 or older who are current or former heavy smokers, non-smokers exposed to significant wood smoke, or diagnosed with COPD. Annual LDCT, spirometry, and serum biomarker tests will be conducted over 3 years, and a follow-up lasting up to 10 years.Read full original descriptionShow less
Lung Cancer Early Detection With Low-dose Computed Tomography in High-risk Individuals: Experience in Mexico
This prospective study aims to detect early-stage lung cancer using low-dose computed tomography (LDCT) in Mexicans aged 50 or older who are current or former heavy smokers, non-smokers exposed to significant wood smoke, or diagnosed with COPD. Annual LDCT, spirometry, and serum biomarker tests will be conducted over 3 years, and a follow-up lasting up to 10 years.
Inclusion: Eligible participants over fifty years old and one of the next criteria:; Current smokers (>20 pack-years); Former smokers (>20 pack-years) who have quit within the past 15 years,; Non-smokers exposed to wood smoke more than 100 hours/year; Patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD).
Exclusion: History of any type of cancer within the last five years, except non-melanoma skin cancer; Symptoms consistent with some malignant neoplasm; People with a poor physical-emotional condition that reduces their life expectancy or does not ensure adherence to the study; Elimination Criteria; Subjects who cannot be examined by tomography due to physical limitations such as weight; Withdrawal of informed consent.